Spero Therapeutics, Inc.·4

Jan 7, 5:07 PM ET

VINK PATRICK V.J.J. 4

4 · Spero Therapeutics, Inc. · Filed Jan 7, 2022

Insider Transaction Report

Form 4
Period: 2022-01-05
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-05$9.03/sh+2,214$19,9922,214 total
    Exercise: $13.19Exp: 2032-01-05Common Stock (2,214 underlying)
Footnotes (2)
  • [F1]This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director.
  • [F2]This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $20,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy.

Documents

2 files